Search Browse Earnings

Celularity Inc — SlamSEC

Celularity Inc

Nasdaq:CELUNasdaq:CELUW

Pharmaceutical Preparations·FLORHAM PARK, NJ

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$22.8M

+26.7% YoY

FY 2024

Adj. EBITDA

-$183.0M

-803.5% margin

FY 2024

Net Income

-$196.3M

-862.0% margin

FY 2024

EPS (Diluted)

-$11.02

FY 2024

Stock Price

$1.27

+4.0%

2026-03-09

52W Range

$1.01 – $4.35

P/E Ratio

-0.1x

Market Cap

$35.9M

Cash

$227,000

FY 2024

Total Debt

$42.7M

FY 2023

Net Debt

$42.5M

FY 2023

Enterprise Value

$78.4M

Debt / EBITDA

-0.2x

FY 2024

EV / EBITDA

-0.4x

Employees

—